Published in PLoS One on March 13, 2014
Clinical and Laboratory Testing for Trichomonas vaginalis Infection. J Clin Microbiol (2015) 0.79
The prevalence of trichomoniasis and associated factors among women treated at a university hospital in southern Brazil. PLoS One (2017) 0.75
Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health (2004) 12.00
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
Untreated gonococcal and chlamydial infection in a probability sample of adults. JAMA (2002) 5.07
Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis (2007) 4.12
Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis (2008) 3.98
The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis (2007) 3.42
The impact of T-ACASI interviewing on reported drug use among men who have sex with men. Subst Use Misuse (2000) 3.40
Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis (2007) 2.85
Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis (2005) 2.55
Consequences of declining survey response rates for smoking prevalence estimates. Am J Prev Med (2004) 2.54
The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis (2005) 2.31
Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis (2006) 1.63
Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 National Health and Nutrition Examination Surveys. Sex Transm Dis (2009) 1.45
Reducing bias in telephone survey estimates of the prevalence of drug use: a randomized trial of telephone audio-CASI. Addiction (2005) 1.45
Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics. Sex Transm Dis (2008) 1.39
Risk behaviors, medical care, and chlamydial infection among young men in the United States. Am J Public Health (2002) 1.31
Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis (2010) 1.29
Trichomonas vaginalis genital infections: progress and challenges. Clin Infect Dis (2011) 1.22
Testing for sexually transmitted infections in a population-based sexual health survey: development of an acceptable ethical approach. J Med Ethics (2012) 1.21
T-ACASI reduces bias in STD measurements: the National STD and Behavior Measurement Experiment. Sex Transm Dis (2008) 1.19
LCR testing for gonorrhoea and chlamydia in population surveys and other screenings of low prevalence populations: coping with decreased positive predictive value. Sex Transm Infect (2003) 1.05
Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations. Sex Transm Dis (2011) 0.96
Update of trichomoniasis. Sex Transm Infect (2002) 0.91
Concurrent sexually transmitted infections (STIs) in sex partners of patients with selected STIs: implications for patient-delivered partner therapy. Clin Infect Dis (2005) 0.89